therapies, cancer can be treated more and more successfully - but what causes lasting damage to the tumors often also has severe side effects. The highly effective therapeutic agents from the anthracycline [...] Clinical Respiratory Research, Pharmaceutical Biotechnology at the Braunschweig site and Personalized Tumor Therapy at the Regensburg site. October 2020 IMTTS researcher Dr. Ankita Garg was awarded with the
Contribution of Veillonella parvula to Pseudomonas aeruginosa mediated pathogenicity in a murine tumor model system. Infection and Immunity, in press. Morano M, Wrobel S, Fregnan F, Ziv-Polat O, Shahar
Park-Simon. 2016. “The Benefit of Baseline Staging-Risk Assessment of Distant Breast Cancer Metastases by Tumor Stage.” Anticancer Research 36(9):4909–14. doi: 10.21873/anticanres.11056. Schäfer, T., M. Klintschar
Seine Arbeiten zur translationalen Entwicklung der mRNA-Impftechnologie haben die Behandlung solider Tumoren maßgeblich verändert. Darüber hinaus hat er als Firmenmitgründer und Wissenschaftsnetzwerker im Kampf
Nicht fündig geworden? Sie haben in den Unterlagen nicht gefunden wonach Sie gesucht haben? Sprechen Sie uns gerne an! Eingangslabor: Tel. +49 511 532 3114 | humangenetik-diagnostik @ mh-hannover.de
Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors. Ann.Surg. 2020. Waldron LS, et al. Diaphragmatic Hernia following Pediatric Liver Transplantation:
Heikenwalder M. Age-Related Gliosis Promotes Central Nervous System Lymphoma through CCL19-Mediated Tumor Cell Retention. Cancer Cell. 2019 Sep 16;36(3):250-267.e9. doi: 10.1016/j.ccell.2019.08.001. PMID:
Organkrebszentren Moderne Krankenversorgung auf höchstem Qualitätsniveau Die Organkrebszentren stellen die Basis der interdisziplinären Patientenversorgung unseres Krebszentrums dar. Sie sind krankhei
Kroeger N, Gauler T, Johannsen M, Bedke J, Grunwald V, Interdisciplinary working group on renal tumors (IAG-N) of the German Cancer Socity (DKG). Systemic treatment of advanced/metastatic renal cell carcinoma [...] context of SARS-CoV-2 pandemic: recommendations from the interdisciplinary working group for renal tumors (IAG-N). J Cancer Res Clin Oncol 2020;146(11):3075-3078 DOI: 10.1007/s00432-020-03341-4 Pfaar O, [...] immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study. BMC Infect Dis 2022;22(1):403
Contribution of Veillonella parvula to Pseudomonas aeruginosa mediated pathogenicity in a murine tumor model system. Infection and Immunity, in press. Morano M, Wrobel S, Fregnan F, Ziv-Polat O, Shahar